PTGS2 and depressive disorder: COX-2, as an inflammatory cytokine, inhibition of COX-2 expression reduces oxidative stress, inflammatory factor release, upregulates 5-HTlA receptors in hippocampal tissue, ameliorates cortical inflammatory response damage, reestablishes monoamine transmitter system homeostasis, and attenuates depression-like behavior (56).